Articles related to BREAST CANCER

As we continue to improve the sensitivity of breast imaging, the need for surgical excision of benign proliferative lesions diagnosed on core needle biopsy remains a contentious topic, calling for careful examination of acceptable excision thresholds, patient preferences, and potential disparities in care.

Explore the groundbreaking findings from the TROPiCS-02 study, revealing sacituzumab govitecan as a potential game-changer in the treatment of endocrine refractory metastatic hormone receptor-positive breast cancer.

A phase II trial showed a significant progression-free survival benefit when patients with HR+/HER2- metastatic breast cancer switched endocrine therapy and received ribociclib, indicating the potential of this treatment strategy for those who progress on endocrine therapy and palbociclib. Learn more about the findings and implications for clinical practice.

The imminent CMS coding changes, leading to massive pay cuts, threaten to significantly reduce the availability of DIEP flap breast reconstruction, a procedure renowned for its superior patient outcomes. The potential repercussions, such as increased health disparities and a loss of specialized surgical skills, underscore the urgent need for policy reconsideration.

Explore this extensive study that highlights the recent major advancements in the prognosis for women with early invasive breast cancer while also emphasizing the impact of personal factors on mortality risk.

Unveiling USPSTF’s New Recommendation for Breast Cancer Screenings The US Preventive Services Task Force (USPSTF) has issued a notable change in breast cancer screening guidelines, shedding light on the growing concern of breast cancer morbidity in the United States. This recommendation has profound implications for early detection and potential reduction in mortality rates.